Platelet activation in inflammatory bowel disease.
10.11817/j.issn.1672-7347.2019.180192
- Author:
Hao WU
1
;
Meihua XU
1
Author Information
1. Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha 410008, China.
- Publication Type:Journal Article
- MeSH:
Blood Platelets;
Endothelial Cells;
Humans;
Inflammatory Bowel Diseases;
Platelet Activation;
Platelet Aggregation Inhibitors
- From:
Journal of Central South University(Medical Sciences)
2019;44(8):931-934
- CountryChina
- Language:Chinese
-
Abstract:
Platelet lineage suggests that it plays a crucial role in immune responses. In recent years, many studies have found that platelet activation is closely related to the activity of inflammatory bowel disease. Activated platelets can release inflammatory mediators, and express surface molecules that mediate inflammation, interact with leukocytes and vascular endothelial cells. It provides a theoretical basis for antiplatelet drugs to treat the inflammatory bowel disease.
